EUVIMEDEUVIMED entdecken
Crossref

Tau-targeting therapy in Alzheimer’s disease: critical advances and future opportunities

Yi Guo, Song Li, Ling-Hui Zeng, Jun Tan

Ageing and Neurodegenerative Diseases · 2022

DOI: 10.20517/and.2022.16 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Ageing and Neurodegenerative Diseases, 2022. Verfasst von Yi Guo und 3 weiteren Autor:innen. Die Arbeit wurde bisher 59-mal zitiert (Crossref). Gefördert von: High-level Talent Foundation of Guizhou Medical University, National Natural Science Foundation of China (NSFC).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by two pathological hallmark lesions: extracellular plaques composed of β-amyloid (Aβ) peptide and intracellular neurofibrillary tangles made up of highly phosphorylated tau protein. Over the past two decades, most disease-modifying therapies against AD have been developed mainly on the basis of the amyloid cascade hypothesis with a focus on Aβ. However, these agents yielded only limited benefits against disease progression, which prompts us to revitalize the long-neglected tau hypothesis. Tau protein is a microtubule-associated protein, which can stabilize microtubules, regulate microtubule assembly, and affect the morphology and growth of neuronal axons. Much more importantly, the degree of tau pathology is more closely related to cognitive decline in AD patients than that of Aβ pathology. Therefore, tau-targeting therapy seems to be a promising approach to combat AD. This review describes the research progress of tau-targeting therapy in AD, with an emphasis on immunotherapy. The current challenges and future perspectives in this field are also discussed.

Förderung

  • High-level Talent Foundation of Guizhou Medical University
  • National Natural Science Foundation of China (NSFC)

Zitieren

APA

Guo, Y., Li, S., Zeng, L., & Tan, J. (2022). Tau-targeting therapy in Alzheimer’s disease: critical advances and future opportunities. Ageing and Neurodegenerative Diseases. https://doi.org/10.20517/and.2022.16

Vancouver

Guo Y, Li S, Zeng L, Tan J. Tau-targeting therapy in Alzheimer’s disease: critical advances and future opportunities. Ageing and Neurodegenerative Diseases. 2022. doi:10.20517/and.2022.16

BibTeX
@article{Guo2022,
  author = {Guo, Yi and Li, Song and Zeng, Ling-Hui and Tan, Jun},
  title = {Tau-targeting therapy in Alzheimer’s disease: critical advances and future opportunities},
  journal = {Ageing and Neurodegenerative Diseases},
  year = {2022},
  doi = {10.20517/and.2022.16}
}
Kostenlos starten →